U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. BioStar Technology International, LLC - 512757 - 12/14/2018
  1. Warning Letters

CLOSEOUT LETTER

BioStar Technology International, LLC MARCS-CMS 512757 —

Delivery Method:
United Parcel Service
Reference #:
WL #24-17 Close-Out Letter
Recipient:
Recipient Name
Ulysses L. Sheretov
Recipient Title
President
BioStar Technology International, LLC
BioStar Technology International, LLC

2912 Colorado Blvd
Los Angeles, CA 90041
United States

Issuing Office:

United States

Dear Mr. Sheretov:

The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter WL # 24-15 issued April 17, 2017. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/
Compliance Branch Director
Office of Human and Animal Food
Division of Human and Animal FeedWest 5

Back to Top